Market Overview:
The global lipoprotein A test kit market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to the increasing prevalence of cardiovascular diseases, technological advancements in lipoprotein A testing, and rising demand for point-of-care diagnostics. Based on application, the global lipoprotein A test kit market is segmented into hospital and clinic settings. The hospital setting is expected to account for a larger share of the market than clinic settings during the forecast period owing to increasing use of point-of-care diagnostics in hospitals.
Product Definition:
A lipoprotein a test kit is used to measure the amount of lipoprotein a in the blood. Lipoprotein a is a type of cholesterol that can increase the risk for heart disease. Measuring the level of lipoprotein a can help determine if someone is at risk for heart disease.
Immunochromatography:
It is also known as the immune chromatographic method. The process involves the use of antibodies which are linked to a chemical substance that changes color depending on the presence or absence of specific antigens in an individual's body.
Turbidimetric Inhibition Immuno Assay:
The turbidimetric inhibition immunoassay (TIIIA) is a method used for measuring the concentration of high-density lipoprotein (HDL) in plasma. The test is performed by adding an excess amount of a substrate, usually cholera toxin, to the sample and then measuring the rate at which it is bound to HDL.
Application Insights:
The market is categorized based on application as hospital, clinic and others. The hospital segment dominated the overall market in terms of revenue in 2017. This can be attributed to factors such as rising prevalence of cardiovascular diseases and growing geriatric population at a global level. In addition, increasing number of patients suffering from acute pancreatitis at a global level is also expected to contribute towards growth during the forecast period.
The other segment includes laboratories, diagnostic centers and drug testing facilities that perform LpA tests outside the conventional laboratory setting such as point-of-care testing or home healthcare testing kits for individuals diagnosed with diabetes or hyperlipidemia who require immediate medical attention but cannot afford to go to a clinical setting for diagnosis due to time constraints imposed by their busy schedule or work pressure respectively.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a large number of manufacturers, distributors, and researchers involved in developing new tests for various disorders. The U.S., being one of the most developed nations with high healthcare expenditure has led to an increase in research activities for development of novel diagnostic techniques such as lipoprotein A test kits.
Asia Pacific is expected to grow at a lucrative rate over the forecast period owing to increasing prevalence rates associated with cardiovascular diseases and diabetes among other reasons due to changing lifestyle habits such as smoking, alcohol consumption, unhealthy diet etc., leading towards increased risk for chronic disorders that require preventive measures such as lipoprotein A test kit usage amongst others. Moreover, growing awareness about early diagnosis will also boost demand during this period (2018-2030).
Growth Factors:
- Increasing prevalence of cardiovascular diseases (CVDs) across the globe is expected to drive the demand for Lipoprotein A Test Kits over the forecast period.
- Growing geriatric population is also anticipated to fuel the growth of this market as elderly people are more susceptible to CVDs.
- Rising awareness about early diagnosis and treatment of CVDs will propel the demand for Lipoprotein A Test Kits in near future.
- Technological advancements in diagnostic kits and increasing R&D investments by key players are likely to create new opportunities for this market in forthcoming years. 5
Scope Of The Report
Report Attributes
Report Details
Report Title
Lipoprotein A Test Kit Market Research Report
By Type
Immunochromatography, Turbidimetric Inhibition Immuno Assay
By Application
Hospital, Clinic
By Companies
Easydiagnosis, Biosino
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
248
Number of Tables & Figures
174
Customization Available
Yes, the report can be customized as per your need.
Global Lipoprotein A Test Kit Market Report Segments:
The global Lipoprotein A Test Kit market is segmented on the basis of:
Types
Immunochromatography, Turbidimetric Inhibition Immuno Assay
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Easydiagnosis
- Biosino
Highlights of The Lipoprotein A Test Kit Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Immunochromatography
- Turbidimetric Inhibition Immuno Assay
- By Application:
- Hospital
- Clinic
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Lipoprotein A Test Kit Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A lipoprotein A test kit is a laboratory tool that allows for the measurement of lipoprotein A levels in blood. Lipoprotein A is a type of cholesterol, and its level can indicate whether an individual has high or low cholesterol levels.
Some of the major players in the lipoprotein a test kit market are Easydiagnosis, Biosino.
The lipoprotein a test kit market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Lipoprotein A Test Kit Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Lipoprotein A Test Kit Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Lipoprotein A Test Kit Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Lipoprotein A Test Kit Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Lipoprotein A Test Kit Market Size & Forecast, 2020-2028
4.5.1 Lipoprotein A Test Kit Market Size and Y-o-Y Growth
4.5.2 Lipoprotein A Test Kit Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Immunochromatography
5.2.2 Turbidimetric Inhibition Immuno Assay
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinic
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Lipoprotein A Test Kit Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Lipoprotein A Test Kit Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Immunochromatography
9.6.2 Turbidimetric Inhibition Immuno Assay
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinic
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Immunochromatography
10.6.2 Turbidimetric Inhibition Immuno Assay
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinic
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Immunochromatography
11.6.2 Turbidimetric Inhibition Immuno Assay
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinic
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Immunochromatography
12.6.2 Turbidimetric Inhibition Immuno Assay
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinic
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Immunochromatography
13.6.2 Turbidimetric Inhibition Immuno Assay
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinic
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Lipoprotein A Test Kit Market: Competitive Dashboard
14.2 Global Lipoprotein A Test Kit Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Easydiagnosis
14.3.2 Biosino
